INTELLIGENCE-1

Completed study

Official Study Title
INTEgration of clinicaL and Laboratory Information to GENerate technological advanCE for the diagnosis of sepsis

Brief Description
INTELLIGENCE-1 is a non-interventional trial to validate the diagnostic accuracy of HemoSpec in the diagnosis of sepsis. HemoSpec is a device that integrates information of whole blood cell count, Raman spectra of circulating white blood cells and serum proteins.

Details
Status: Completed
Study Type: Non-Interventional
Study phase: II
Study sites: 5 sites in Greece
Actual enrolment: 173 participants

ClinicalTrials.gov Identifier: NCT03306186

Study Start: October 2017
Study Completion: March 2018

Condition/Disease studied: Sepsis
Keywords: diagnosis; prognosis